ProCE Banner Activity

Long-Acting Growth Hormone Therapy: Best Practices for Pediatrics

Clinical Thought

In discussing the available long-acting growth hormone therapies, as well as current safety and efficacy data, I share my thoughts on best practices for the appropriate use of these novel treatment options in clinical practice.

Released: August 14, 2023

Expiration: August 14, 2024

Share

Faculty

Bradley Miller

Bradley Miller, MD, PhD

Professor
Department of Pediatrics
Division Director
Pediatric Endocrinology
University of Minnesota Medical School 
Medical Director
Discovery Clinic
M Health Fairview Masonic Children's Hospital
Minneapolis, Minnesota

Provided by

Provided by Clinical Care Options, LLC, in partnership with Endocrine Society

ProCE Banner
ProCE Banner

Supporters

This activity is supported by an educational grant from Novo Nordisk.

Novo Nordisk

Disclosure

Primary Author

Bradley Miller, MD, PhD

Professor
Department of Pediatrics
Division Director
Pediatric Endocrinology
University of Minnesota Medical School 
Medical Director
Discovery Clinic
M Health Fairview Masonic Children's Hospital
Minneapolis, Minnesota

Bradley S. Miller, MD, PhD: consultant/advisor/speaker: Ascendis, BioMarin, Bristol-Myers Squibb, Endo Pharmaceuticals, GenSci, Tolmar; researcher: AbbVie, Aeterna Zentaris, Alexion, Foresee, Lumos Pharma, Novo Nordisk, Opko Health, Pfizer, Sangamo.